ID RPIA_HUMAN Reviewed; 311 AA. AC P49247; Q541P9; Q96BJ6; DT 01-FEB-1996, integrated into UniProtKB/Swiss-Prot. DT 24-JUL-2007, sequence version 3. DT 02-SEP-2026, entry version 210. DE RecName: Full=Ribose-5-phosphate isomerase {ECO:0000305}; DE EC=5.3.1.6 {ECO:0000269|PubMed:14988808}; DE AltName: Full=Phosphoriboisomerase; GN Name=RPIA {ECO:0000312|HGNC:HGNC:10297}; Synonyms=RPI; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Guo J.H., Yu L.; RT "Cloning and characterization of human ribose 5-phosphate isomerase (RPI) RT gene."; RL Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 186-311. RC TISSUE=B-cell; RX PubMed=7758956; DOI=10.1016/0378-1119(94)00901-4; RA Apel T.W., Scherer A., Adachi T., Auch D., Ayane M., Reth M.; RT "The ribose 5-phosphate isomerase-encoding gene is located immediately RT downstream from that encoding murine immunoglobulin kappa."; RL Gene 156:191-197(1995). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [6] RP METHYLATION [LARGE SCALE ANALYSIS] AT ARG-52, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Colon carcinoma; RX PubMed=24129315; DOI=10.1074/mcp.o113.027870; RA Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M., RA Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V., RA Bedford M.T., Comb M.J.; RT "Immunoaffinity enrichment and mass spectrometry analysis of protein RT methylation."; RL Mol. Cell. Proteomics 13:372-387(2014). RN [7] RP VARIANT RPIAD VAL-135, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=14988808; DOI=10.1086/383204; RA Huck J.H.J., Verhoeven N.M., Struys E.A., Salomons G.S., Jakobs C., RA van der Knaap M.S.; RT "Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose RT phosphate pathway associated with a slowly progressive RT leukoencephalopathy."; RL Am. J. Hum. Genet. 74:745-751(2004). CC -!- FUNCTION: Catalyzes the reversible conversion of ribose-5-phosphate to CC ribulose 5-phosphate and participates in the first step of the non- CC oxidative branch of the pentose phosphate pathway. CC {ECO:0000269|PubMed:14988808}. CC -!- CATALYTIC ACTIVITY: CC Reaction=aldehydo-D-ribose 5-phosphate = D-ribulose 5-phosphate; CC Xref=Rhea:RHEA:14657, ChEBI:CHEBI:58121, ChEBI:CHEBI:58273; CC EC=5.3.1.6; Evidence={ECO:0000269|PubMed:14988808}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14658; CC Evidence={ECO:0000305|PubMed:14988808}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14659; CC Evidence={ECO:0000305|PubMed:14988808}; CC -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-ribose CC 5-phosphate from D-ribulose 5-phosphate (non-oxidative stage): step CC 1/1. {ECO:0000269|PubMed:14988808}. CC -!- INTERACTION: CC P49247; Q8N5M1: ATPAF2; NbExp=12; IntAct=EBI-744831, EBI-1166928; CC P49247; Q9NWQ9: C14orf119; NbExp=3; IntAct=EBI-744831, EBI-725606; CC P49247; Q6IPU0: CENPP; NbExp=8; IntAct=EBI-744831, EBI-10250303; CC P49247; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-744831, EBI-742054; CC P49247; Q75MZ5: FOXP2; NbExp=4; IntAct=EBI-744831, EBI-10255915; CC P49247; Q9H8Y8: GORASP2; NbExp=8; IntAct=EBI-744831, EBI-739467; CC P49247; Q9UJY1: HSPB8; NbExp=3; IntAct=EBI-744831, EBI-739074; CC P49247; Q8TBB1: LNX1; NbExp=5; IntAct=EBI-744831, EBI-739832; CC P49247; Q96HA8: NTAQ1; NbExp=8; IntAct=EBI-744831, EBI-741158; CC P49247; P22061: PCMT1; NbExp=4; IntAct=EBI-744831, EBI-353343; CC P49247; P22061-2: PCMT1; NbExp=4; IntAct=EBI-744831, EBI-12386584; CC P49247; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-744831, EBI-79165; CC P49247; Q06124: PTPN11; NbExp=4; IntAct=EBI-744831, EBI-297779; CC P49247; Q9H0X6: RNF208; NbExp=3; IntAct=EBI-744831, EBI-751555; CC P49247; P49247: RPIA; NbExp=4; IntAct=EBI-744831, EBI-744831; CC P49247; O00560: SDCBP; NbExp=3; IntAct=EBI-744831, EBI-727004; CC P49247; O75716: STK16; NbExp=4; IntAct=EBI-744831, EBI-749295; CC P49247; Q99757: TXN2; NbExp=6; IntAct=EBI-744831, EBI-2932492; CC -!- DISEASE: Ribose 5-phosphate isomerase deficiency (RPIAD) [MIM:608611]: CC An autosomal recessive inborn error of polyols metabolism characterized CC by highly elevated level of ribitol and arabitol in brain and body CC fluids. Clinical features include leukoencephalopathy, psychomotor CC retardation from early life, neurologic regression, and a mild CC sensorimotor neuropathy. {ECO:0000269|PubMed:14988808}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC -!- SIMILARITY: Belongs to the ribose 5-phosphate isomerase family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAK95569.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY050633; AAK95569.1; ALT_FRAME; mRNA. DR EMBL; BC015529; AAH15529.2; -; mRNA. DR EMBL; L35035; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS2004.2; -. DR RefSeq; NP_653164.2; NM_144563.3. DR AlphaFoldDB; P49247; -. DR SMR; P49247; -. DR BioGRID; 116594; 78. DR FunCoup; P49247; 3075. DR IntAct; P49247; 44. DR MINT; P49247; -. DR NDEx; IQUERY-CP-RPIA; 5 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000283646; -. DR BindingDB; P49247; -. DR ChEMBL; CHEMBL5725137; -. DR DrugBank; DB01756; 4-phospho-L-threonic acid. DR GlyGen; P49247; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; P49247; -. DR PhosphoSitePlus; P49247; -. DR BioMuta; RPIA; -. DR DMDM; 156637353; -. DR jPOST; P49247; -. DR MassIVE; P49247; -. DR PaxDb; 9606-ENSP00000283646; -. DR PeptideAtlas; P49247; -. DR ProteomicsDB; 55976; -. DR Pumba; P49247; -. DR Antibodypedia; 32248; 166 antibodies from 27 providers. DR DNASU; 22934; -. DR Ensembl; ENST00000283646.5; ENSP00000283646.3; ENSG00000153574.10. DR GeneID; 22934; -. DR KEGG; hsa:22934; -. DR MANE-Select; ENST00000283646.5; ENSP00000283646.3; NM_144563.3; NP_653164.2. DR UCSC; uc002ste.4; human. DR AGR; HGNC:10297; -. DR ClinPGx; PA34659; -. DR CTD; 22934; -. DR DisGeNET; 22934; -. DR GeneCards; RPIA; -. DR HGNC; HGNC:10297; RPIA. DR HPA; ENSG00000153574; Tissue enhanced (bone). DR MalaCards; RPIA; -. DR MIM; 180430; gene. DR MIM; 608611; phenotype. DR OpenTargets; ENSG00000153574; -. DR Orphanet; 440706; Ribose-5-P isomerase deficiency. DR VEuPathDB; HostDB:ENSG00000153574; -. DR eggNOG; KOG3075; Eukaryota. DR GeneTree; ENSGT00390000004352; -. DR HOGENOM; CLU_056590_0_2_1; -. DR InParanoid; P49247; -. DR OMA; ACHVQEK; -. DR OrthoDB; 1555531at2759; -. DR PAN-GO; P49247; 3 GO annotations based on evolutionary models. DR PhylomeDB; P49247; -. DR BRENDA; 5.3.1.6; 2681. DR PathwayCommons; P49247; -. DR Reactome; R-HSA-5659996; RPIA deficiency: failed conversion of R5P to RU5P. DR Reactome; R-HSA-6791461; RPIA deficiency: failed conversion of RU5P to R5P. DR Reactome; R-HSA-71336; Pentose phosphate pathway. DR SignaLink; P49247; -. DR SIGNOR; P49247; -. DR UniPathway; UPA00115; UER00412. DR Agora; ENSG00000153574; -. DR BioGRID-ORCS; 22934; 250 hits in 1174 CRISPR screens. DR ChiTaRS; RPIA; human. DR GenomeRNAi; 22934; -. DR Pharos; P49247; Tbio. DR PRO; PR:P49247; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; P49247; protein. DR Bgee; ENSG00000153574; Expressed in secondary oocyte and 205 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005739; C:mitochondrion; HTP:FlyBase. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0048029; F:monosaccharide binding; IEA:Ensembl. DR GO; GO:0004751; F:ribose-5-phosphate isomerase activity; EXP:Reactome. DR GO; GO:0006014; P:D-ribose metabolic process; IBA:GO_Central. DR GO; GO:0006098; P:pentose-phosphate shunt; TAS:Reactome. DR GO; GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; IBA:GO_Central. DR CDD; cd01398; RPI_A; 1. DR FunFam; 3.40.50.1360:FF:000013; Ribose 5-phosphate isomerase A; 1. DR FunFam; 3.30.70.260:FF:000018; Ribose-5-phosphate isomerase A; 1. DR Gene3D; 3.30.70.260; -; 1. DR Gene3D; 3.40.50.1360; -; 1. DR HAMAP; MF_00170; Rib_5P_isom_A; 1. DR InterPro; IPR037171; NagB/RpiA_transferase-like. DR InterPro; IPR020672; Ribose5P_isomerase_typA_subgr. DR InterPro; IPR004788; Ribose5P_isomerase_type_A. DR NCBIfam; NF001924; PRK00702.1; 1. DR NCBIfam; TIGR00021; rpiA; 1. DR PANTHER; PTHR11934; RIBOSE-5-PHOSPHATE ISOMERASE; 1. DR PANTHER; PTHR11934:SF0; RIBOSE-5-PHOSPHATE ISOMERASE; 1. DR Pfam; PF06026; Rib_5-P_isom_A; 1. DR SUPFAM; SSF75445; D-ribose-5-phosphate isomerase (RpiA), lid domain; 1. DR SUPFAM; SSF100950; NagB/RpiA/CoA transferase-like; 1. PE 1: Evidence at protein level; KW Disease variant; Isomerase; Methylation; Neuropathy; Phosphoprotein; KW Proteomics identification; Reference proteome. FT CHAIN 1..311 FT /note="Ribose-5-phosphate isomerase" FT /id="PRO_0000158521" FT REGION 22..67 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 22..32 FT /note="Gly residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 57..67 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 52 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0007744|PubMed:24129315" FT MOD_RES 106 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:23186163" FT VARIANT 135 FT /note="A -> V (in RPIAD; dbSNP:rs121918591)" FT /evidence="ECO:0000269|PubMed:14988808" FT /id="VAR_019122" FT CONFLICT 207 FT /note="D -> V (in Ref. 3; L35035)" FT /evidence="ECO:0000305" FT CONFLICT 239 FT /note="L -> V (in Ref. 3; L35035)" FT /evidence="ECO:0000305" SQ SEQUENCE 311 AA; 33269 MW; 4ED587A40F10223D CRC64; MQRPGPFSTL YGRVLAPLPG RAGGAASGGG GNSWDLPGSH VRLPGRAQSG TRGGAGNTST SCGDSNSICP APSTMSKAEE AKKLAGRAAV ENHVRNNQVL GIGSGSTIVH AVQRIAERVK QENLNLVCIP TSFQARQLIL QYGLTLSDLD RHPEIDLAID GADEVDADLN LIKGGGGCLT QEKIVAGYAS RFIVIADFRK DSKNLGDQWH KGIPIEVIPM AYVPVSRAVS QKFGGVVELR MAVNKAGPVV TDNGNFILDW KFDRVHKWSE VNTAIKMIPG VVDTGLFINM AERVYFGMQD GSVNMREKPF C //